glp-1 medications pros and cons Part 2 of a 3-Part Series; for Weight Loss 2026 Employee Benefits Trends: Should

Dual and Triple Agonists: The next generation of medications, such as Tirzepatide (which targets both GLP-1 and GIP receptors), are already demonstrating even greater efficacy for weight loss and blood sugar control

57 ZhuZ

Its a little surprising that diet soda drinkers were more like to develop two particular components of metabolic syndrome: larger waistlines and higher fasting glucose levels (results consistent with the New York study results)

Suganuma Y, Shimizu T, Sato T, Morii T, Fujita H, Harada Sassa M et al (2020) Magnitude of slowing gastric emptying by glucagon-like peptide-1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes